A new blood test that could help doctors identify whether a patient has Alzheimer’s disease was cleared by the FDA last week.

La Jolla researchers say there is a pressing need for cost-effective tests for markers of Alzheimer’s disease and related dementia in groups considered underrepresented in studies — particularly ...

One of the most frightening things about Alzheimer's disease is how difficult it is to diagnose early. Now, University of ...

Researchers at Lund University in Sweden have developed a digital cognitive test for diagnosing Alzheimer's disease that is intended for use in primary care. "This digital test, which patients perform ...

This transcript has been edited for clarity. Hi. I’m Art Caplan. I'm at the Division of Medical Ethics at NYU Grossman School of Medicine in New York City. The FDA recently cleared, for the first time ...

The U.S. Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other causes of cognitive decline, providing a broader understanding of when the ...

Scientists have designed a new cognitive test that diagnoses patients more accurately with Alzheimer's. The digital test times how long it takes patients to remember objects and make word associations ...

The U.S. FDA recently approved a new blood test to diagnose Alzheimer’s disease. The test, called Lumipulse, measures two proteins in plasma: pTau217 and ß-Amyloid 1-42. These proteins clump together ...